Introduction of Prof. Armstrong
As a principle investigator for the STREAM trial, can you comment on the relevance of this trial in the real world of STEMI management?
What can we learn from the STREAM trial?
What implications does STREAM have with regard to clinical practice in a large STEMI network?
Do the substudies of STREAM provide any additional information?
As a cardiologist: if you had to send one message out to all emergency physicians regarding the management of STEMI patients, what would it be?